KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $133.39 $156.84 Friday, 26th Apr 2024 ASND stock ended at $135.90. This is 0.752% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.81% from a day low at $133.39 to a day high of $139.81.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Mar 23, 2022 $122.39 $122.96 $116.74 $117.14 237 500
Mar 22, 2022 $110.86 $125.88 $110.86 $123.34 450 436
Mar 21, 2022 $116.91 $126.79 $111.11 $111.58 327 044
Mar 18, 2022 $118.49 $121.04 $116.90 $117.44 500 348
Mar 17, 2022 $122.47 $124.27 $116.96 $118.49 380 700
Mar 16, 2022 $110.28 $123.44 $110.28 $122.93 714 200
Mar 15, 2022 $108.94 $111.28 $104.49 $109.44 914 200
Mar 14, 2022 $112.00 $113.00 $96.97 $102.64 1 712 900
Mar 11, 2022 $103.47 $105.82 $101.04 $102.18 410 700
Mar 10, 2022 $102.69 $104.83 $101.63 $102.49 523 000
Mar 09, 2022 $106.97 $109.48 $104.30 $104.85 156 600
Mar 08, 2022 $105.89 $108.53 $104.99 $105.77 242 500
Mar 07, 2022 $104.08 $105.88 $103.22 $105.56 173 600
Mar 04, 2022 $104.56 $106.80 $102.25 $104.53 233 500
Mar 03, 2022 $107.76 $108.50 $102.00 $105.52 422 000
Mar 02, 2022 $108.74 $109.41 $105.63 $106.48 556 400
Mar 01, 2022 $114.32 $117.00 $108.06 $108.83 302 100
Feb 28, 2022 $107.67 $113.94 $107.34 $112.39 272 100
Feb 25, 2022 $109.16 $109.16 $106.23 $108.52 240 400
Feb 24, 2022 $103.81 $109.80 $103.81 $107.19 424 600
Feb 23, 2022 $111.60 $112.30 $105.50 $107.30 300 500
Feb 22, 2022 $111.50 $113.67 $108.09 $111.02 120 500
Feb 18, 2022 $113.22 $114.61 $109.69 $111.99 208 500
Feb 17, 2022 $116.37 $119.81 $114.21 $114.74 222 900
Feb 16, 2022 $122.32 $124.80 $114.43 $117.71 334 800
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT